ArticlePolymers2025
Development and Characterization of Antimicrobial Chitosan/Polyethylene Oxide/Bacterial Cellulose Nanofibers.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Mineral-Botanical Hybrid Nanofibrous Dressing for Post-Surgical Melanoma Wound Healing.Polymers · 2026Article
- PLA/BC/lard nanofiber composites as next-generation burn wound dressings.RSC advances · 2026Article
- From Design to Application: Advanced Cellulose Scaffolds for Engineered Tissue Regeneration.Polymers · 2026Review
- Chitosan/PEO Nanofibers as a Delivery Platform for Sustained Release ofInternational journal of molecular sciences · 2025Article
- Multifunctional Application of Electrospun Fiber.Polymers · 2025Article
- A Review of Chitosan-Based Electrospun Nanofibers for Food Packaging: From Fabrication to Function and Modeling Insights.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces novel chitosan (CS) and polyethylene oxide (PEO) copolymers reinforced with bacterial cellulose (BC) to fabricate nanofibers using the electrospinning method. SEM analysis confirmed uniform nanofiber formation, with CS/PEO/BC nanofibers (~240 nm) exhibiting a larger diameter than CS/PEO ones (~190 nm). FTIR spectroscopy confirmed BC integration, while Differential scanning calorimetry analysis indicated minimal impact on glass transition temperature. Notably, as compared to CS/PEO nanofibers, the CS/PEO/BC ones demonstrated superior swelling capacity, accelerated biodegradation, and enhanced mechanical (i.e., tensile) properties, with maximum stress and strain values of ~3.41 MPa and ~0.01% vs. ~2.14 MPa and ~0.01%. Antimicrobial assays confirmed activity against bacterial strains, and biocompatibility tests showed high cell viability at day seven (99.26% for CS/PEO/BC nanofibers). These findings highlight the potential of CS/PEO/BC nanofibers as promising candidates for tissue engineering, offering improved strength, biodegradability, and antimicrobial properties.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.